Budenofalk

Budenofalk

budesonide

Manufacturer:

Dr Falk

Marketer:

Darya-Varia
Concise Prescribing Info
Contents
Budesonide
Indications/Uses
Induction of remission in patients w/ mild to moderate Crohn's disease w/ involvement of the ileum &/or descending colon.
Dosage/Direction for Use
1 cap 3 times daily. Duration of administration: 8 wk.
Administration
Should be taken on an empty stomach: Take 30 min before meals. Swallow whole w/ plenty of fluid, do not chew.
Contraindications
Local infections of the intestine. Severe disorders of liver function. Infant & young childn.
Special Precautions
TB, HTN, DM, osteoporosis, peptic ulcer, glaucoma, cataract, family history of diabetes or glaucoma, hepatic impairment. Pregnancy & lactation.
Adverse Reactions
Allergic exanthema, red striae, petechiae, ecchymosis, steroid acne, delayed wound healing, contact dermatitis, muscle weakness, osteoporosis, aseptic necrosis of the bone, glaucoma, cataract, depression, irritability, euphoria, GI discomfort, duodenal ulcer, pancreatitis, Cushing's syndrome, HTN, increased risk of thrombosis & vasculitis, delayed immune response.
Drug Interactions
Live viral vaccines, cardiac glycosides, K-sparing diuretics, ketoconazole, troleandomycin, erythromycin, cyclosporine, cimetidine, cholestyramine.
MIMS Class
GIT Regulators, Antiflatulents & Anti-Inflammatories
ATC Classification
A07EA06 - budesonide ; Belongs to the class of corticosteroids acting locally. Used in the treatment of intestinal inflammation.
Presentation/Packing
Form
Budenofalk cap 3 mg
Packing/Price
50's (Rp1,063,500/pak)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in